RARA CRAFT DATABASE for FDA Medical Devices
510(k)K251717

FDA DEVICE FACTS

Freedom® Total Knee System – Titanium Tibial Base Plate

Maxx Orthopedics, Inc.

FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。

DECISION DATEJune 26, 2025PRODUCT CODEJWH

Indications for use

The Freedom® Total Knee System is indicated for the following:  Severe knee joint pain, loss of mobility, and disability due to: rheumatoid arthritis, osteoarthritis, traumatic arthritis, polyarthritis.  Correction of functional deformities.  Post-traumatic loss of knee joint contour, particularly when there is patellofemoral erosion, dysfunction, or prior patellectomy.  Moderate valgus, varus, or flexion trauma.  Knee fractures untreatable by other methods.  Revision surgery where sufficient bone stock and so ft tissue integrity are present (For PCK Components and Primary PCK Components only). The Freedom® Total Knee System – Titanium Tibial Base Plate is intended for cemented and single use only.

See the full product information製品情報をすべて見るには

Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。

Start free 7-day access7日間無料で利用するLog inログイン

OFFICIAL FDA SOURCES

FDA Record and Public Document Status

Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。

Information reviewed:情報の確認日: September 1, 2026